Single-cell atlas links lung-cancer cells to the risk of spread
Researchers analysed tissue from 454 people. This is not yet a test for routine care.
A study published in Nature Cancer on 12 November 2026 describes LuCaS+, an atlas of non-small cell lung cancer. The team read gene activity in cell nuclei from stored tumour tissue of 454 patients at German university hospitals. The first analysis included 364 people from Berlin and Cologne. A separate check included 90 people from Munich. In total there were more than 2.5 million nuclei.
Certain groups of tumour cells were linked to a higher risk that the cancer would spread. Together with the surrounding immune, connective-tissue and blood-vessel cells, the model predicted outcome in this dataset more closely than the usual classification by tumour size and lymph-node involvement. That is an association, not a new treatment. The atlas is freely available to researchers. Further experiments have to show whether it can lead to therapies.
View matching trials
You will find all new trials in the categories Lungs and airways.
Sources
- Neuer Lungenkrebs-Atlas: Das Risiko von Metastasen messen (opens in a new tab) · Deutsches Konsortium für Translationale Krebsforschung (DKTK) · Accessed on